merrion street

WuXi Biologics, a Hong Kong-listed global open-access biologics technology platform company, in a new biologics drug substance manufacturing facility on the Industrial Development Authority’s (IDA) greenfield site in Mullagharlin in Dundalk, Co. Louth.

This state-of-the-art facility-of-the-future will be built upon the novel approach WuXi Biologics has pioneered deploying multiple single-use bioreactors for commercial biomanufacturing and is also designed to be able to run continuous bioprocessing, a next generation manufacturing technology to be first implemented globally in this campus.

The manufacturing project in a 26-hectare campus, the company’s first site outside of China, is supported by the Irish Government through IDA Ireland. 

An Taoiseach Leo Varadkar, said:

It’s the first sizable Greenfield project from China in the pharma sector and I am delighted to see it located here in Dundalk. It’s also the latest in a number of investments in this town which has become a hub for a range of sectors, mainly in the new knowledge based and pharmaceutical sectors.  In 2017 there were 24 IDA-supported companies in the county, and the number of jobs created by them has tripled from 1,300 in 2010 to almost 4,000. It’s all part of the Government’s goal to increase regional investment and associated jobs by up to 40 per cent.

Minister for Enterprise, Heather Humphreys welcomed the announcement,

This huge €325 million investment is a great vote of confidence in Ireland and reinforces our image as a global centre of excellence in Biologics. This investment will result in the creation of over 400 highly skilled jobs over 5 years as well as approximately 700 construction jobs.